Literature DB >> 23653434

Attention control in mood and anxiety disorders: evidence from the antisaccade task.

Ben Ainsworth1, Matthew Garner.   

Abstract

The antisaccade task (in which participants must suppress a reflexive saccade towards a sudden, peripheral stimulus and generate a volitional saccade in the opposite direction) is considered a measure of cognitive inhibition. The task has been used to examine cognitive control deficits in several neuropsychiatric conditions, most notably schizophrenia. This commentary summarizes recent evidence from antisaccade tasks in mood and anxiety disorders, with reference to neuropsychological models and psychopharmacological mechanisms.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23653434     DOI: 10.1002/hup.2320

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  5 in total

1.  Anxiety-potentiated amygdala-medial frontal coupling and attentional control.

Authors:  O J Robinson; M Krimsky; L Lieberman; K Vytal; M Ernst; C Grillon
Journal:  Transl Psychiatry       Date:  2016-06-07       Impact factor: 6.222

2.  Yogic Breathing Instruction in Patients with Treatment-Resistant Generalized Anxiety Disorder: Pilot Study.

Authors:  Nupur Tiwari; Michelle Sutton; Matthew Garner; David S Baldwin
Journal:  Int J Yoga       Date:  2019 Jan-Apr

3.  Attentional Control in Bilingualism: An Exploration of the Effects of Trait Anxiety and Rumination on Inhibition.

Authors:  Julia Ouzia; Peter Bright; Roberto Filippi
Journal:  Behav Sci (Basel)       Date:  2019-08-19

4.  The relationship between physical exercise and mobile phone addiction among Chinese college students: Testing mediation and moderation effects.

Authors:  Miaolin Zeng; Siyu Chen; Xiangyi Zhou; Jincheng Zhang; Xin Chen; Jingquan Sun
Journal:  Front Psychol       Date:  2022-10-03

5.  Evaluating psychological interventions in a novel experimental human model of anxiety.

Authors:  Ben Ainsworth; Jemma E Marshall; Daniel Meron; David S Baldwin; Paul Chadwick; Marcus R Munafò; Matthew Garner
Journal:  J Psychiatr Res       Date:  2015-02-12       Impact factor: 4.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.